Anabolic Therapy in Postmenopausal Osteoporosis
Latest Information Update: 16 May 2023
At a glance
- Drugs Denosumab (Primary) ; Romosozumab (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 11 May 2023 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2022 Planned End Date changed from 1 Mar 2024 to 1 May 2024.
- 14 Jul 2022 Planned primary completion date changed from 1 Mar 2024 to 1 May 2024.